
|Articles|August 31, 2016
Supplements and Featured Publications
- Evaluation of Clinical Outcomes and Costs Based on Prescribed Dose Level of Renin-Angiotensin-Aldost
- Volume 22
- Issue 11
eAppendix
Advertisement
Articles in this issue
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on AJMC
1
Most Favored Nation Drug Pricing Moves Forward, but Experts Warn Details Are Still Missing
2
Medicaid Work Requirements Set to Leave Millions Without Insurance
3
Oncology Landscape Continues to Evolve With Expanded Indications, First-in-Class Therapies
4
Baricitinib Leads to Significant Hair Regrowth in Adolescents With Severe Alopecia Areata
5















































